Page last updated: 2024-09-03

juliflorine and Acute Confusional Senile Dementia

juliflorine has been researched along with Acute Confusional Senile Dementia in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahmad, VU; Ahmed, A; Azim, MK; Choudhary, MI; Ghayur, MN; Gilani, AU; Jalil, S; Khalid, A; Lodhi, MA; Nawaz, SA; Rode, BM1

Other Studies

1 other study(ies) available for juliflorine and Acute Confusional Senile Dementia

ArticleYear
Juliflorine: a potent natural peripheral anionic-site-binding inhibitor of acetylcholinesterase with calcium-channel blocking potential, a leading candidate for Alzheimer's disease therapy.
    Biochemical and biophysical research communications, 2005, Jul-15, Volume: 332, Issue:4

    Topics: Alkaloids; Alzheimer Disease; Animals; Binding Sites; Calcium; Calcium Channels; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Humans; Hydrogen Bonding; Inhibitory Concentration 50; Kinetics; Models, Chemical; Models, Molecular; Molecular Conformation; Neutrophils; Protein Binding; Protein Conformation; Torpedo; Tyrosine

2005